Market Research

Stable Isotope Labeled Compounds Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Deuterium, Oxygen-18, Carbon-13, Nitrogen-15); By Application (Medical Diagnostics, Industrial, Research); By End

Best Price Guarantee Length Publisher Published Date SKU
from $4,850 400 Pages BlueWeave Consulting September, 2023 BLWC18285342
Best Price Guarantee
Price from $4,850
Length 400 Pages
Publisher BlueWeave Consulting
Published Date September, 2023
SKU BLWC18285342

Stable Isotope Labeled Compounds Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Deuterium, Oxygen-18, Carbon-13, Nitrogen-15); By Application (Medical Diagnostics, Industrial, Research); By End User (Academic & Research Institutions, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)


Global Stable Isotope Labeled Compounds Market Size Set to Touch USD 397 Million by 2029

Global stable isotope labeled compounds market is flourishing because of an increasing research and development activities in the pharmaceutical and biotechnology sector and growing focus on treating the increasing prevalence of diseases.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global stable isotope labeled compounds market size at USD 303.5 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global stable isotope labeled compounds market size to grow at a CAGR of 3.9% reaching a value of USD 396.71 million by 2029. Major growth drivers for the global stable isotope labeled compounds market include an increasing surge in research activities and growing trend in analytical research within the pharmaceutical and biotechnology sector. The rising incidence of cancer has notably boosted analytical investigations using stable isotope-labeled compounds. The market is set to thrive, primarily due to increasing demand for analytical activities, particularly in personalized medicine and pharmaceuticals. This convergence presents an opportunity for strong market growth. In 2022, the United States witnessed around 1.91 million new cancer cases, notably affecting the genital and digestive systems, further emphasizing the market's potential. Stable isotope tracing's role in understanding nutraceuticals' impact on cancer metabolism, as well as proteomics research, contributed to market expansion. These advances supported expectations of robust market growth. However, high cost of stable isotope labeled compounds and lack of skilled professionals are anticipated to restrain the overall market growth during the forecast period.

Global Stable Isotope Labeled Compounds Market – Overview

Stable isotope labeling involves the utilization of non-radioactive isotopes as tracers for modeling various chemical and biochemical systems. These isotopes function as distinctive markers for compounds, detectable through techniques such as nuclear magnetic resonance (NMR) and mass spectrometry (MS). Commonly employed stable isotopes encompass 2H, 13C, and 15N. Researchers, particularly those engaged in metabolism-mediated toxicity studies, have shown significant interest in stable isotope-labeled compounds. Their significance has grown substantially in assessing in vivo metabolism across a wide spectrum of metabolic investigations. Beyond metabolomics research, stable isotope-labeled compounds are experiencing increasing utilization in environmental analysis, proteomics, and medical diagnostic research.

Impact of COVID-19 on Global Stable Isotope Labeled Compounds Market

COVID-19 pandemic had a positive impact on the global stable isotope labeled compounds market. The emergence of the pandemic prompted a surge in research and development efforts worldwide as companies and institutions sought to combat the virus and devise effective management strategies. During the pandemic period, the global stable isotope labeled compounds market experienced noteworthy growth due to heightened demand for stable isotope-labeled compounds, driven by their crucial role in research related to the virus, such as investigations into the structure and dynamics of membrane proteins in pathogens like SARS-CoV-2. As the acute phase of the pandemic subsided, the market transitioned into a post-pandemic phase, and it is expected to continue its growth trajectory. The lessons learned and the increased utilization of stable isotope-labeled compounds during the pandemic are likely to contribute to healthy market expansion during the forecast period.

Global Stable Isotope Labeled Compounds Market – By End User

On the basis of end user, the global stable isotope labeled compounds market is divided into Academic & Research Institutions, Hospital & Diagnostic Centers, and Pharmaceutical & Biotechnology Companies segments. The pharmaceutical & biotechnology companies segment is expected to hold the highest share in the global stable isotope labeled compounds market by end user during the forecast period. These industries heavily rely on stable isotopes for drug discovery, development, and toxicity studies. Additionally, the growing focus on precision medicine and personalized therapies has intensified the demand for stable isotope-labeled compounds in these sectors. Moreover, the significant investments made by pharmaceutical giants in research and development further reinforce their prominence in utilizing stable isotopes for innovative drug-related research, ultimately contributing to their high market share.

Competitive Landscape

Major players operating in the global stable isotope labeled compounds market include TAIYO NIPPON SANSO CORPORATION, PerkinElmer Inc., Alsachim, Isoflex, Merck KGaA, URENCO, 3C Molecular, Trace Sciences International, Cambridge Isotope Laboratories, Inc., IsoSciences, LLC, Medical Isotopes, Inc., and Omicron Biochemicals, Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Stable Isotope Labeled Compounds Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Stable Isotope Labeled Compounds Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.


1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global Stable Isotope Labeled Compounds Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Increase in research activities in the pharmaceutical and biotechnology sectors
3.2.1.2. Growing prevalence of diseases
3.2.2. Restraints
3.2.2.1. High cost of stable isotope labeled compounds
3.2.2.2. Lack of skilled professionals
3.2.3. Opportunities
3.2.3.1. Pharmaceutical industry growth
3.2.3.2. Emerging applications
3.2.4. Challenges
3.2.4.1. Production complexity
3.2.4.2. Competition
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Global Stable Isotope Labeled Compounds Market Overview
4.1. Market Size & Forecast, 2019–2029
4.1.1. By Value (USD Million)
4.2. Market Share and Forecast
4.2.1. By Type
4.2.1.1. Deuterium
4.2.1.2. Oxygen-18
4.2.1.3. Carbon-13
4.2.1.4. Nitrogen-15
4.2.2. By Application
4.2.2.1. Medical Diagnostics
4.2.2.2. Industrial
4.2.2.3. Research
4.2.2.4. Others
4.2.3. By End User
4.2.3.1. Academic & Research Institutions
4.2.3.2. Hospital & Diagnostic Centers
4.2.3.3. Pharmaceutical & Biotechnology Companies
4.2.3.4. Others
4.2.4. By Region
4.2.4.1. North America
4.2.4.2. Europe
4.2.4.3. Asia Pacific (APAC)
4.2.4.4. Latin America (LATAM)
4.2.4.5. Middle East and Africa (MEA)
5. North America Stable Isotope Labeled Compounds Market
5.1. Market Size & Forecast, 2019–2029
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Type
5.2.2. By Application
5.2.3. By End User
5.2.4. By Country
5.2.4.1. United States
5.2.4.1.1. By Type
5.2.4.1.2. By Application
5.2.4.1.3. By End User
5.2.4.2. Canada
5.2.4.2.1. By Type
5.2.4.2.2. By Application
5.2.4.2.3. By End User
6. Europe Stable Isotope Labeled Compounds Market
6.1. Market Size & Forecast, 2019–2029
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.2.4.1. Germany
6.2.4.1.1. By Type
6.2.4.1.2. By Application
6.2.4.1.3. By End User
6.2.4.2. United Kingdom
6.2.4.2.1. By Type
6.2.4.2.2. By Application
6.2.4.2.3. By End User
6.2.4.3. Italy
6.2.4.3.1. By Type
6.2.4.3.2. By Application
6.2.4.3.3. By End User
6.2.4.4. France
6.2.4.4.1. By Type
6.2.4.4.2. By Application
6.2.4.4.3. By End User
6.2.4.5. Spain
6.2.4.5.1. By Type
6.2.4.5.2. By Application
6.2.4.5.3. By End User
6.2.4.6. Belgium
6.2.4.6.1. By Type
6.2.4.6.2. By Application
6.2.4.6.3. By End User
6.2.4.7. Russia
6.2.4.7.1. By Type
6.2.4.7.2. By Application
6.2.4.7.3. By End User
6.2.4.8. The Netherlands
6.2.4.8.1. By Type
6.2.4.8.2. By Application
6.2.4.8.3. By End User
6.2.4.9. Rest of Europe
6.2.4.9.1. By Type
6.2.4.9.2. By Application
6.2.4.9.3. By End User
7. Asia-Pacific Stable Isotope Labeled Compounds Market
7.1. Market Size & Forecast, 2019–2029
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.2.4.1. China
7.2.4.1.1. By Type
7.2.4.1.2. By Application
7.2.4.1.3. By End User
7.2.4.2. India
7.2.4.2.1. By Type
7.2.4.2.2. By Application
7.2.4.2.3. By End User
7.2.4.3. Japan
7.2.4.3.1. By Type
7.2.4.3.2. By Application
7.2.4.3.3. By End User
7.2.4.4. South Korea
7.2.4.4.1. By Type
7.2.4.4.2. By Application
7.2.4.4.3. By End User
7.2.4.5. Australia & New Zealand
7.2.4.5.1. By Type
7.2.4.5.2. By Application
7.2.4.5.3. By End User
7.2.4.6. Indonesia
7.2.4.6.1. By Type
7.2.4.6.2. By Application
7.2.4.6.3. By End User
7.2.4.7. Malaysia
7.2.4.7.1. By Type
7.2.4.7.2. By Application
7.2.4.7.3. By End User
7.2.4.8. Singapore
7.2.4.8.1. By Type
7.2.4.8.2. By Application
7.2.4.8.3. By End User
7.2.4.9. Vietnam
7.2.4.9.1. By Type
7.2.4.9.2. By Application
7.2.4.9.3. By End User
7.2.4.10. Rest of APAC
7.2.4.10.1. By Type
7.2.4.10.2. By Application
7.2.4.10.3. By End User
8. Latin America Stable Isotope Labeled Compounds Market
8.1. Market Size & Forecast, 2019–2029
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.2.4.1. Brazil
8.2.4.1.1. By Type
8.2.4.1.2. By Application
8.2.4.1.3. By End User
8.2.4.2. Mexico
8.2.4.2.1. By Type
8.2.4.2.2. By Application
8.2.4.2.3. By End User
8.2.4.3. Argentina
8.2.4.3.1. By Type
8.2.4.3.2. By Application
8.2.4.3.3. By End User
8.2.4.4. Peru
8.2.4.4.1. By Type
8.2.4.4.2. By Application
8.2.4.4.3. By End User
8.2.4.5. Rest of LATAM
8.2.4.5.1. By Type
8.2.4.5.2. By Application
8.2.4.5.3. By End User
9. Middle East & Africa Stable Isotope Labeled Compounds Market
9.1. Market Size & Forecast, 2019–2029
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.2.4.1. Saudi Arabia
9.2.4.1.1. By Type
9.2.4.1.2. By Application
9.2.4.1.3. By End User
9.2.4.2. UAE
9.2.4.2.1. By Type
9.2.4.2.2. By Application
9.2.4.2.3. By End User
9.2.4.3. Qatar
9.2.4.3.1. By Type
9.2.4.3.2. By Application
9.2.4.3.3. By End User
9.2.4.4. Kuwait
9.2.4.4.1. By Type
9.2.4.4.2. By Application
9.2.4.4.3. By End User
9.2.4.5. South Africa
9.2.4.5.1. By Type
9.2.4.5.2. By Application
9.2.4.5.3. By End User
9.2.4.6. Nigeria
9.2.4.6.1. By Type
9.2.4.6.2. By Application
9.2.4.6.3. By End User
9.2.4.7. Algeria
9.2.4.7.1. By Type
9.2.4.7.2. By Application
9.2.4.7.3. By End User
9.2.4.8. Rest of MEA
9.2.4.8.1. By Type
9.2.4.8.2. By Application
9.2.4.8.3. By End User
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. Global Stable Isotope Labeled Compounds Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global Stable Isotope Labeled Compounds Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
12.1. TAIYO NIPPON SANSO CORPORATION
12.2. PerkinElmer Inc.
12.3. Alsachim
12.4. Isoflex
12.5. Merck KGaA
12.6. URENCO
12.7. 3C Molecular
12.8. Trace Sciences International
12.9. Cambridge Isotope Laboratories, Inc.
12.10. IsoSciences, LLC
12.11. Medical Isotopes, Inc.
12.12. Omicron Biochemicals, Inc.
12.13. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations

$4,850
$5,750
$8,150

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings